NCT04988100

Brief Summary

In this study, the investigators aim to prove that performing splenic artery ligation in living donor liver transplantation for patients with portal hypertension is beneficial for early graft function postoperatively. The investigators will be analyzing trend of LFT's (liver function tests) after surgery, time for normalization of bilirubin, INR (international normalised ratio) and decrease in ascites, morbidity, mortality, ICU (intensive care unit) and total hospital stay.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 3, 2021

Completed
29 days until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

August 17, 2021

Status Verified

August 1, 2021

Enrollment Period

2 years

First QC Date

July 25, 2021

Last Update Submit

August 14, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Incidence of early graft dysfunction

    Number of patients who develop early graft dysfunction in each group

    first postoperative month

  • Time to normalisation of ascites output

    time to normalisation of ascites output (in days)

    first postoperative month

  • Time to normalisation of INR

    time to normalisation of INR (in days)

    first postoperative month

  • Time to normalisation of bilirubin

    time to normalisation of bilirubin (in days)

    first postoperative month

Secondary Outcomes (4)

  • Morbidity

    first postoperative month

  • ICU stay

    first postoperative month

  • Mortality

    first postoperative month

  • Total hospital stay

    first postoperative month

Study Arms (2)

Patients who undergo Splenic artery ligation

EXPERIMENTAL

If inclusion criteria are met, these group of patients will undergo splenic artery ligation .

Procedure: splenic artery ligation

No splenic artery ligation

ACTIVE COMPARATOR

If inclusion criteria are met, these group of patients will not undergo splenic artery ligation.

Procedure: No intervention

Interventions

Splenic artery will be ligated just after takeoff from coeliac trunk at the level of body of pancreas

Patients who undergo Splenic artery ligation

Splenic artery is not ligated despite the presence of portal hyperperfusion

No splenic artery ligation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients undergoing Living Donor Liver Transplantation(LDLT) accepted according to hospital protocol.
  • Patients who have Portal Venous Pressure (PVP) \> 15 mm Hg after reperfusion .

You may not qualify if:

  • Patients who have Portal Venous Pressure (PVP) \> 15 mm Hg after reperfusion.
  • Patients who had splenectomy.
  • Patients who have splenic artery aneurysm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Gad EH, Alsebaey A, Lotfy M, Eltabbakh M, Sherif AA. Complications and mortality after adult to adult living donor liver transplantation: A retrospective cohort study. Ann Med Surg (Lond). 2015 Apr 25;4(2):162-71. doi: 10.1016/j.amsu.2015.04.021. eCollection 2015 Jun.

    PMID: 26005570BACKGROUND
  • Abdeldayem H, Kashkoush S, Hegab BS, Aziz A, Shoreem H, Saleh S. Analysis of donor motivations in living donor liver transplantation. Front Surg. 2014 Jul 8;1:25. doi: 10.3389/fsurg.2014.00025. eCollection 2014.

    PMID: 25593949BACKGROUND
  • Umeda Y, Yagi T, Sadamori H, Matsukawa H, Matsuda H, Shinoura S, Mizuno K, Yoshida R, Iwamoto T, Satoh D, Tanaka N. Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation. 2008 Sep 15;86(5):673-80. doi: 10.1097/TP.0b013e318181e02d.

    PMID: 18791439BACKGROUND
  • Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y, Hirohashi K, Tanaka AK. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003 Apr 27;75(8):1313-7. doi: 10.1097/01.TP.0000063707.90525.10.

    PMID: 12717222BACKGROUND
  • Jiang SM, Zhou GW, Zhang R, Peng CH, Yan JQ, Wan L, Shen C, Chen H, Li QY, Shen BY, Li HW. Role of splanchnic hemodynamics in liver regeneration after living donor liver transplantation. Liver Transpl. 2009 Sep;15(9):1043-9. doi: 10.1002/lt.21797.

    PMID: 19718645BACKGROUND
  • Garcia-Valdecasas JC, Fuster J, Charco R, Bombuy E, Fondevila C, Ferrer J, Ayuso C, Taura P. Changes in portal vein flow after adult living-donor liver transplantation: does it influence postoperative liver function? Liver Transpl. 2003 Jun;9(6):564-9. doi: 10.1053/jlts.2003.50069.

    PMID: 12783396BACKGROUND
  • Wu TJ, Dahiya D, Lee CS, Lee CF, Chou HS, Chan KM, Lee WC. Impact of portal venous hemodynamics on indices of liver function and graft regeneration after right lobe living donor liver transplantation. Liver Transpl. 2011 Sep;17(9):1035-45. doi: 10.1002/lt.22326.

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 25, 2021

First Posted

August 3, 2021

Study Start

September 1, 2021

Primary Completion

September 1, 2023

Study Completion

October 1, 2023

Last Updated

August 17, 2021

Record last verified: 2021-08